Literature DB >> 12820328

Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images.

R E Friedrich1, B Korf, C Fünsterer, V F Mautner.   

Abstract

This article describes some types of growth in plexiform neurofibroma (PNF) on magnetic resonance images (MRI). This tumor is almost exclusively associated with NF1. On MRI, the tumor is depicted as a hyperintensive area on T2-weighted images. We distinguished 3 patterns of tumor growth: first, the superficial and non-invasive tumors, that are restricted to the cutis and subcutis, only eventually having outgrowth to the muscles beneath and are slow growing. Second, the displacing PNF that develop in deeper layers of the skin or within the body. They can grow to a large extent but do not invade adjacent muscles or skin. Thirdly, the invasive type with no visible margins that cannot be resected without adjacent structures or organs. A combination of these tumors can sometimes be noted, e.g. a displacing tumorous nerve developing in a large lumpy, non-invasive PNF. These categories might be used as a current guideline for medical advice, surgical treatment planning and medication trials.

Entities:  

Mesh:

Year:  2003        PMID: 12820328

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.

Authors:  V F Mautner; M Hartmann; L Kluwe; R E Friedrich; C Fünsterer
Journal:  Neuroradiology       Date:  2006-01-24       Impact factor: 2.804

Review 2.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Management of massive lower limb plexiform neurofibromatosis--when to intervene?

Authors:  K T Power; J Giannas; Z Babar; D A McGrouther
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

4.  Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Caglayan T Tuzcu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Authors:  Rosa Nguyen; Kimberly Jett; Gordon J Harris; Wenli Cai; Jan M Friedman; Victor-Felix Mautner
Journal:  J Neurooncol       Date:  2013-10-29       Impact factor: 4.130

6.  Resection of small plexiform neurofibromas in neurofibromatosis type 1 children.

Authors:  Reinhard E Friedrich; Rainer Schmelzle; Melanie Hartmann; Carsten Fünsterer; Victor-F Mautner
Journal:  World J Surg Oncol       Date:  2005-01-31       Impact factor: 2.754

7.  Peripheral nerve sheath tumors of the upper extremity and hand in patients with neurofibromatosis type 1: topography of tumors and evaluation of surgical treatment in 62 patients.

Authors:  Reinhard E Friedrich; Caroline Diekmeier
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2017-12-05

8.  The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.

Authors:  Lennart Well; Anna Jaeger; Hildegard Kehrer-Sawatzki; Said Farschtschi; Maxim Avanesov; Markus Sauer; Manuela Tavares de Sousa; Peter Bannas; Thorsten Derlin; Gerhard Adam; Victor F Mautner; Johannes M Salamon
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

9.  Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.

Authors:  Lennart Well; Kimberly Döbel; Lan Kluwe; Peter Bannas; Said Farschtschi; Gerhard Adam; Victor-Felix Mautner; Johannes Salamon
Journal:  PLoS Genet       Date:  2021-05-05       Impact factor: 5.917

10.  Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.

Authors:  Rosa Nguyen; Eva Dombi; Brigitte C Widemann; Jeffrey Solomon; Carsten Fuensterer; Lan Kluwe; Jan M Friedman; Victor-Felix Mautner
Journal:  Orphanet J Rare Dis       Date:  2012-10-04       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.